Leonard Valentino: Deeply Grateful to be Nominated for the 2026 Galien Patient First Award
Leonard Valentino, President of WFH USA, shared The Galien Foundation’s post on LinkedIn:
“I am deeply grateful and humbled to be nominated for the 2026 Galien Patient First Award.
Thank you to the review committee The Galien Foundation for recognizing the work of the Bleeding Disorders Research Collaborative (BDRC) and our commitment to advancing a new model of “patient-led” research.
At the heart of the BDRC is a simple but powerful belief: people living with bleeding disorders should not merely participate in research, they should help lead and inform it as lived experience experts (LEEs). By elevating patient perspectives throughout the research process, we can generate evidence that is more meaningful, relevant, and impactful.
This recognition belongs to the entire community that continues to champion patient-centered innovation.
Learn more about the BDRC.”
The Galien Foundation shared a post on LinkedIn:
2026 Galien Patient First Award Nominees anounced:
Winners will be announced on Oct 29 during the Galien Patient Summit.
-
Sep 14, 2026, 15:53Leonard Valentino: Advancing a New Model of Patient-Led Research
-
Sep 14, 2026, 15:48Adishwar Rao: LAAC vs Oral Anticoagulation in Atrial Fibrillation
-
Sep 14, 2026, 15:36Lesley Van Wyk: Hemolytic Anemia Quick Revision – Tips and Tricks
-
Sep 14, 2026, 15:35Maha Othman: ISTH-BAT Reference Ranges Validated Across Five Continents in Children
-
Sep 14, 2026, 15:30Umberto Pensato։ Left Ventricular Dysfunction and DOAC Benefit in ESUS
-
Sep 14, 2026, 15:22Meral Kayikcioglu: Why Do Women and Men Differ in LDL-C Management?
-
Sep 14, 2026, 15:22James Crowley: The Complex Role of CRP in Cardiovascular Risk and Atherosclerosis
-
Sep 14, 2026, 15:16Factor XIII Deficiency An Often-Missed Bleeding Disorder
-
Sep 14, 2026, 15:07Raffaele Piccolo: Heparin Against Jellyfish Venom?